Management ChangeApr 26, 2026, 05:25 AM
NRSN CMO Dr. Ferenc Tracik to Step Down, Remain Advisor
AI Summary
NeuroSense Therapeutics Ltd. announced that Dr. Ferenc Tracik will step down from his role as Chief Medical Officer, effective April 27, 2026. Dr. Tracik will continue to support the Company as an independent advisor, providing strategic medical guidance on the PrimeC program. His departure is not a result of any disagreement with the Company.
Key Highlights
- Dr. Ferenc Tracik to step down as Chief Medical Officer, effective April 27, 2026.
- Dr. Tracik will continue to support NeuroSense Therapeutics as an independent advisor.
- He will provide strategic medical guidance on the Company's PrimeC program.
- Departure is not due to any disagreement with the Company's operations, policies, or practices.
Price Impact
More from NRSN